News by Country: American Samoa

The In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules
A detailed review of the overall landscape of companies offering in silico drug discovery services for large molecules

January 15, 2021

Over 90 firms are actively involved in providing in silico services for drug discovery of different types of biologics
Presently, in silico tools / approaches are available for the identification

January 15, 2021

In silico drug discovery services market is likely to be worth USD 124 million by 2030
Majority of the companies offer structure-based drug design focused on early stage drug discovery of a range of large molecules, including antibodies, proteins and peptides

January 15, 2021

In silico drug discovery services market is likely to be worth USD 124 million by 2030
A detailed assessment of the current market landscape of companies offering in silico drug discovery services for large molecules.

January 15, 2021

The “Global Handheld Ultrasound Imaging Devices Market, 2020-2030”
A detailed brand positioning analysis of key industry players, highlighting the current perceptions regarding their proprietary brands by taking into consideration several relevant aspects

January 15, 2021

Several players are currently engaged in the development / manufacturing over 100 point-of-care handheld ultrasound scanners
According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.

January 15, 2021

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030
Around 100 handheld ultrasound imaging devices, incorporating different transducer arrays and advanced software, are being actively used by physicians to scan different body parts.

January 15, 2021

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030
A detailed assessment of the current market landscape of companies engaged in the development / manufacturing of handheld ultrasound imaging devices

January 15, 2021

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030, growing at a CAGR of 11%, claims Roots Analysis
According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.

January 15, 2021

The ‘‘Microbial Contract Biomanufacturing Market, 2020-2030’’
A detailed proprietary 2×2 representation that was developed to assess the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments.

January 14, 2021

Over 115 companies, across the world, claim to offer a variety of product development
Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various aspects of their respective microbial biologic development programs.

January 14, 2021

The microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%, till 2030
The market features the presence of several well-established players across the globe

January 14, 2021

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030, predicts Roots Analysis
Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs

January 14, 2021

The microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030, growing at a CAGR of 8.7%, claims Roots Analysis
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment

January 14, 2021

The “In Vitro ADME Testing Services Market, 2019-2030”
A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2005-2018

January 14, 2021

Over 90 firms are actively involved in providing in vitro ADME testing services; of these,
Currently, there are a number of contract research organizations (CROs) that claim to have the necessary capabilities to offer in vitro ADME services.

January 14, 2021

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%
Several players involved in this domain are steadily expanding their capabilities in order to enhance their respective in the in vitro

January 14, 2021

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030,
With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME)

January 14, 2021

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%, predicts Roots Analysis
Nearly 60% of these companies are small and mid-sized firms. Further, close to 35% of the CROs engaged in this domain, claim to provide services to both pharmaceutical companies and academic institutes.

January 14, 2021

‘Human Microbiome Market: Focus on Therapeutics (including gut-brain axis targeting drugs),
A detailed business portfolio analysis based on an attractiveness and competitiveness (AC) framework

January 13, 2021

Presently, 260 drug candidates are being evaluated in clinical
Despite having captured the interest of several venture capital firms and big pharma players

January 13, 2021

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030,
Prevalent trends indicate that microbiome drugs and diagnostics market is poised to grow significantly

January 13, 2021

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030
An assessment of the most commonly targeted therapeutic indications and details of microbiome-based drugs.

January 13, 2021

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030,
The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community

January 13, 2021

The “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution)
An informative analysis of contemporary Google Trends in the time period between 2015 and 2020 (till July) and insights from the recent news articles related digital therapeutic solutions, indicating the increasing popularity of this domain.

January 13, 2021

Over 100 industry players are engaged in evaluating the potential of several prescription
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions.

January 13, 2021

The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis
The projected market opportunity is anticipated to be well-distributed across different therapeutic areas, distribution channels and key geographical regions

January 13, 2021

The global digital therapeutics market is projected to be worth over USD 8.8 billion by 2030, predicts Roots Analysis
Elaborate profiles of key industry players that offer a several digital therapeutic solutions (shortlisted on the basis of the product portfolio).

January 13, 2021

The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis
The market in Asia-Pacific regions is anticipated to grow at a relatively faster pace (23.2%). In 2030,

January 13, 2021

The “Prefilled Syringe Fill / Finish Service Providers, 2020-2030”
A detailed demand and supply assessment of geographies, based on a number of parameters.

January 12, 2021

Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes.
Biopharmaceutical manufacturers have been reported to outsource more than 30% of their fill / finish operations to contract service providers.

January 12, 2021

The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%, till 2030
The market landscape features the presence of well- established players in the domain

January 12, 2021

The prefilled syringe fill / finish services market.
Tabulated profiles of key players (shortlisted based on a proprietary criterion) across key geographies, such as North America, Europe and Asia-Pacific.

January 12, 2021

The ‘Prefilled Syringes Market (5th edition), 2019-2030'
A detailed discussion on various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes and the companies involved in developing and manufacturing such solutions.

January 12, 2021

Presently, around 80 types of prefilled syringes are available in the market
Prefilled syringes present an attractive packaging option that doubles as an easy-to-use drug delivery device

January 12, 2021

The prefilled syringes market is projected to grow at an annualized rate of ~5%, till 2030
Several big pharma companies are actively engaged in strengthening their pipeline of injectable drugs across various therapeutic areas

January 12, 2021

The prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis
A detailed overview of the current market landscape of companies engaged in manufacturing prefilled syringes.

January 12, 2021

The “Global Psychedelic Therapeutics Market, 2020-2030”
An insightful analysis of clinical trial sites where the studies have been / are being conducted for evaluation of various psychedelic therapeutics

January 11, 2021

Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic
The over USD 6.5 billion (by 2030) financial opportunity within the psychedelic therapeutics

January 11, 2021

Global Psychedelic therapeutics market is projected to grow at an annualized rate of ~15%, till 2030
“Global Psychedelic Therapeutics Market, 2020-2030”

January 11, 2021

Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis
Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.

January 11, 2021

The “Proteome Profiling Services Market, 2020-2030”
A detailed review of the impact of the COVID-19 pandemic on the overall proteome profiling services market.

January 11, 2021

The market is fragmented, featuring the presence of both industry and non-industry players that are involved in providing proteome profiling services
As a result, proteome profiling has become an indispensable part of modern drug discovery and development process, as well as disease diagnosis.

January 11, 2021

The proteome profiling services market is projected to grow at an annualized rate of ~15%, till 2030
The current landscape includes a mix of both established players and new entrants; close to 40% of the companies offering proteome profiling services were established over the last two decades

January 11, 2021

The proteome profiling services market is projected to be worth USD 16 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
The study also features a detailed analysis of the key drivers and trends related to this evolving domain.

January 11, 2021

The “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic)
Detailed profiles of the key industry players engaged in the development of stem cell-based therapies

January 8, 2021

More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy products
Recent studies suggest that mesenchymal stem cells mesenchymal stem cells can be effectively used to improve patients' resistance to the SARS-CoV-2 virus induced pneumonia leading to speedy recovery.

January 8, 2021

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis
More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy products for the treatment of a variety of disease indications.

January 8, 2021

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis
A detailed clinical trial analysis on more than 540 completed, ongoing and planned studies of various stem cell therapies, highlighting prevalent trends across various relevant parameters

January 8, 2021

 111 123